BioWorld

Feb. 4, 2003

Abgenix, Chugai Collaborate On Human Antibody Therapies

Pharmacopeia Enters Two Deals, Receives Milestone From Another

Rigel Reducing Staff Again; Phase II Expected This Year

Other News To Note

Biogen To Pay Schering $55M Bringing MS Dispute To End

With an appeals court decision that Biogen Inc. must pay another $55 million to Schering AG in their patent fight over beta interferon, the longstanding dispute apparently has been laid to rest. (BioWorld Today) Read More

Bush Budget Allocates $6B To Fund Vaccine Research

Today's news in brief

BioWorld

BioWorld briefs for Dec. 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 11, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

US lawmakers demand that Kennedy be held accountable

BioWorld

As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...

Medline plans record-setting $5.37B IPO

BioWorld MedTech

Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...